SCHEMBL20248284

SCHEMBL20248284

Cc1cc(-c2ccc(CP)c(C)c2)ccc1CP

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ TSHR P16473 2/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ RXRA P19793 2/20 0.41
▸ RXRB P28702 2/20 0.41
▸ RXRG P48443 1/20 0.40
▸ HSD17B1 P14061 3/20 0.33
▸ TP53 P04637 2/20 0.33
▸ HSD17B2 P37059 2/20 0.33
▸ HPGD P15428 1/20 0.33
▸ ESR2 Q92731 1/20 0.32
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ S1PR1 P21453 2/20 0.32
▸ MCL1 Q07820 1/20 0.31
▸ BRD4 O60885 1/20 0.31
▸ BRD9 Q9H8M2 1/20 0.31
▸ S1PR3 Q99500 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26032094 0.89 ALDH1A1 (0.37) ALDH1A1CYP3A4TSHRTDP1RXRA
SCHEMBL18308729 0.89 ALDH1A1 (0.37) ALDH1A1CYP3A4TSHRTDP1RXRA
SCHEMBL18308756 0.89 ALDH1A1 (0.37) ALDH1A1CYP3A4TSHRTDP1RXRA
SCHEMBL18308731 0.89 ALDH1A1 (0.37) ALDH1A1CYP3A4TSHRTDP1RXRA
SCHEMBL18308750 0.87 ALDH1A1 (0.35) ALDH1A1CYP3A4TSHRTDP1RXRA
SCHEMBL18308808 0.85 HSD17B1 (0.38) ALDH1A1CYP3A4TSHRTDP1RXRA
SCHEMBL18308806 0.84 RXRA (0.36) ALDH1A1CYP3A4TSHRTDP1RXRA
SCHEMBL18308775 0.82 HSD17B1 (0.40) ALDH1A1CYP3A4TSHRTDP1RXRA
SCHEMBL18308776 0.81 RXRA (0.35) ALDH1A1CYP3A4TSHRTDP1RXRA
SCHEMBL18308809 0.81 HSD17B1 (0.35) ALDH1A1CYP3A4TSHRTDP1RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180163137-A1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS MERCK PATENT GMBH (DE) 2018-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180163137-A1 POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS VCL, ILK, LCP1 ALDH1A1 4650/4885CYP3A4 1701/4885TSHR 4834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback